Faricimab helped improve vision in previously untreated patients with neovascular age-related macular degeneration, according to a real-world study presented at Retina 2025. Ferhina S. Ali, MD, MPH, ...

A multidisciplinary team of researchers from the Istituto Italiano di Tecnologia (IIT-Italian Institute of Technology) and ...

Volunteers are needed to help run a leading sight loss charity support group, which supports people affected by macular ...

“We are enthusiastic about getting patients started in the OCU200 Phase 1 clinical trial and sharing not only safety but preliminary efficacy data as the study progresses,” said Dr. Huma Qamar, Chief ...

Regenxbio's rolling BLA submission completion of RGX-121 for the treatment of patients with MPS II expected in Q1 of 2025.

The Amsler grid is a simple and effective tool often used to detect early signs of macular degeneration. This is a grid of ...

Health scientists from the University of Virginia have found a previously unknown contributor to harmful blood vessel growth ...

During my visit to CES 2025, I sought out a pair of special smart glasses that could give me hope for my son's future.

Under the terms of the option agreement, which was signed in December 2024, Bausch + Lomb has secured the exclusive option to cquire InflammX Therapeutics during an agreed-upon option period based on ...

Researchers have developed a therapy to treat Stargardt disease, the most common form of inherited macular degeneration, ...

Researchers have developed a highly efficient gene editing therapy that could potentially treat Stargardt disease, the most ...